What happened
DWS Limited, an Australian IT, business and management consulting company listed on the ASX with a market capitalisation of approximately $118.65 million as at 18 September 2020, entered into a Scheme Implementation Agreement on 21 September 2020 with HCL Australia Services Pty Limited, a wholly-owned subsidiary of the Indian-listed HCL Technologies Limited. Under the agreement HCL agreed to acquire all issued ordinary shares in DWS by means of a members' scheme of arrangement for a cash consideration of $1.20 per DWS share. If implemented, the scheme would result in DWS becoming a wholly-owned subsidiary of HCL and being delisted from the ASX, with implementation anticipated for 11 December 2020.
A Scheme Booklet was prepared containing the explanatory statement required by s 412 of the Corporations Act 2001 (Cth). The booklet included a detailed description of the scheme, its advantages and disadvantages, a recommendation from all DWS directors that shareholders vote in favour in the absence of a superior proposal or a change in the independent expert's conclusion, and an independent expert report from BDO Corporate Finance (East Coast) Pty Ltd. The expert valued DWS shares in the range of $1.12 to $1.33 and concluded that the $1.20 scheme consideration was fair and reasonable, albeit slightly below the mid-point of $1.23.
A draft of the Scheme Booklet was lodged with ASIC on 13 October 2020 and later amended. ASIC was given at least 14 days' notice of the first court hearing and provided a letter dated 29 October 2020 stating that it did not propose to appear or make submissions opposing the scheme at the first hearing. On 30 October 2020 Beach J heard the originating process in which DWS sought orders under s 411(1) convening a meeting of shareholders to be held electronically on 3 December 2020. The hearing occurred in the context of the COVID-19 pandemic, and the orders sought relied upon the modifications to the Corporations Act contained in the Corporations (Coronavirus Economic Response) Determination (No.3) 2020 permitting virtual meetings.
His Honour made the orders sought on 30 October 2020 and published reasons on 2 November 2020. The orders provided for dispatch of the Scheme Booklet (electronically to shareholders with nominated email addresses and by post or airmail to others), appointment of a chair, conduct of voting by poll, proxy deadlines, dispensation from certain rules in the Federal Court (Corporations) Rules 2000 (Cth), publication of a notice of the second court hearing, and adjournment of the approval application to 4 December 2020. The reasons systematically addressed performance risk, shareholder warranties, the break fee, exclusivity arrangements and directors' interests, particularly the post-scheme consultancy agreement with the managing director Mr Danny Wallis and his associated entity.
Why the court decided this way
Beach J began by confirming that the jurisdictional preconditions in s 411(1) were satisfied: an arrangement was proposed between a Pt 5.1 body and its members, ASIC had received 14 days' notice, and the Court was satisfied that ASIC had had a reasonable opportunity to examine the Scheme and the draft explanatory statement ([14]-[15]). The discretion was therefore enlivened. The function at the first court hearing is supervisory, focused on procedural and substantive requirements including adequate disclosure, with only limited consideration of fairness ([16]). The judge applied the well-known threshold from Re Foundation Healthcare Ltd (2002) 42 ACSR 252 at [44]: a meeting should not be ordered only if the scheme is so blatantly unfair or inappropriate on its face that it should be stopped in its tracks. No such issue arose here.
On performance risk, the judge noted that although HCL was not a party to the Scheme itself, the mechanism adopted eliminated material risk. The Scheme prevented any transfer of shares until the consideration had been deposited in cleared funds into a trust account operated by DWS, and HCL had executed a Deed Poll containing a direct covenant in favour of scheme shareholders to provide the consideration ([19]-[20]). This reflected accepted market practice and removed any basis for refusing to convene the meeting.
The break fee of $1,581,600 was examined in detail ([22]-[26]). It was payable in defined circumstances (third-party proposal leading to 50% acquisition within 12 months, material breach, entry into a competing agreement, or adverse change in director recommendation outside permitted circumstances) but not if the Scheme became effective or if shareholders simply voted it down. The fee represented approximately 1.3% of the equity value at announcement, was not disproportionate, reflected costs incurred by HCL, and had been a condition of HCL entering the transaction. These factors led to the conclusion that the break fee did not bar convening.
Exclusivity provisions in the Scheme Implementation Agreement (no shop, no due diligence and no talk) were found to be in standard form and operated only until the earlier of termination, 31 March 2021 or implementation ([27]-[30]). A fiduciary carve-out applied to the no talk and no due diligence restrictions. The five-month period was reasonable, the provisions were prominently disclosed, and therefore they presented no obstacle.
The most extended analysis concerned the directors' interests, particularly the consultancy agreement entered into by DWS (at HCL's request) with Mr Wallis and DBW Constructions Pty Ltd ([31]-[49]). The agreement provided for six months of integration and transitional services at $30,000 per month plus GST, terminable on 30 or 60 days' notice. Full disclosure was made in the Scheme Booklet. Beach J first applied the Sovereign Life Assurance Co v Dodd class test (adopted in Re Healthscope (2019) 139 ACSR 608) and held that the consultancy did not create a separate class: the rights were not so dissimilar as to make it impossible for Mr Wallis and other shareholders to consult together with a view to their common interest ([38]-[40]).
On the question whether Mr Wallis could nevertheless recommend the Scheme, Beach J preferred the approach of Black J in Re Villa World Ltd (2019) 139 ACSR 550, Robson J in Re SMS Management and Technology Limited [2017] VSC 257 and O'Callaghan J in Re Kidman Resources Ltd [2019] FCA 1226 over the contrary view expressed by O'Bryan J in Re Wellcome Group Limited [2019] FCA 1655. He reasoned that shareholders would be confused by a nuanced distinction between board support and no voting recommendation, that the commercial context of a scheme implementation agreement usually requires directors to take active steps to promote the transaction, and that full disclosure neutralises any bias at both board and member levels ([42]-[48]). ASIC's lack of concern and Mr Wallis's substantial 42.71% shareholding further supported permitting the recommendation. The arrangements were not class-creating and did not preclude the directors from making a recommendation.
Finally, the judge was satisfied that the Scheme Booklet met the three limbs of s 412: it explained the effect of the arrangement and directors' interests, contained the prescribed information, and included all material information within the directors' knowledge ([53]-[60]). Verification procedures were adequate, registration by ASIC was expected, and s 411(17) presented no bar because ASIC was likely to provide a no-objection statement at the second hearing and there was no evidence of any proscribed purpose ([50]-[52]). In conclusion, the Scheme was of a nature that, if it obtained the statutory majorities, would likely be approved at the second hearing, and the meeting should therefore be convened ([65]-[67]).
Before and after state of the law
Prior to this judgment the law on first court hearings was settled in broad terms by authorities such as Re Foundation Healthcare Ltd, which supplied the "blatantly unfair" threshold. The treatment of performance risk through Deed Polls and pre-transfer payment mechanisms had become standard and was endorsed in cases such as Re SMS Management and Technology Limited. Break fees in the 1-2% range had been routinely accepted where not triggered merely by failure to obtain shareholder approval. Exclusivity provisions with fiduciary carve-outs were commonplace.
On director interests and recommendations the law was less uniform. Re SMS, Re Kidman Resources and Re Villa World had permitted a director with an incentive or post-transaction benefit to make a recommendation provided the interest was disclosed and the benefit was not so material as to create a separate class. Conversely, Re Wellcome Group had expressed the view that a director could support putting the scheme to members while declining to recommend it on the basis that his or her view might be biased. Beach J's reasons represent a clear preference for the former line, grounding the preference in both practical shareholder understanding and the commercial reality of scheme implementation agreements that require boards to promote the transaction consistently with their duties.
The judgment also sits within the COVID-19 modifications to meeting requirements. Part 2 of the Corporations (Coronavirus Economic Response) Determination (No.3) 2020 had altered the Corporations Act to permit wholly virtual meetings. This decision confirmed that such orders are appropriate where government directions restrict physical gatherings.
After the decision the law on director recommendations in schemes where a benefit is received is more settled in favour of permitting a disclosed recommendation. The analysis of the consultancy agreement as not class-creating reinforces the narrow application of the Sovereign Life Assurance test in members' schemes. The emphasis on the commercial context of friendly takeovers implemented by scheme (unanimous board resolution, exclusivity, break fees and promotional obligations) has become part of the orthodox understanding of why a director's board-level support and member-level recommendation should align once disclosure is adequate. The decision also illustrates the continuing supervisory but non-merits-based role of the Court at the first hearing, preserving the ultimate commercial decision for shareholders.
Key passages with plain-English translation
Paragraph [16] states: "the proposed scheme appears now to be on its face 'so blatantly unfair or otherwise inappropriate that it should be stopped in its tracks before going any further' (Re Foundation Healthcare Ltd … at [44] per French J)." In plain English this means the judge's job at the first hearing is not to decide whether the deal is good value, but to check whether anything is so obviously wrong that shareholders should not even be allowed to vote. If the answer is no, the meeting goes ahead.
At [19]-[20] the reasons explain that the Scheme "prevent[s] any transfer of the scheme shares to HCL unless and until the scheme consideration has been issued" and that HCL executed a Deed Poll. Translation: even though HCL is not formally part of the Scheme, shareholders are protected because their shares cannot be taken until the cash is sitting in a trust account, and HCL has signed a separate promise that the Court can enforce. This removes the risk that shareholders hand over their shares and never get paid.
The class test discussion at [38] quotes Bowen LJ from Sovereign Life Assurance and applies it to the consultancy: the rights of Mr Wallis "are not so dissimilar … as to make it impossible for [him] to consult together with a view to their common interest." Plain English: even though Mr Wallis will get a consultancy fee after the deal, his interests as a shareholder are still close enough to everyone else's that they can all sit in the same meeting and vote as one group. No separate meeting is needed.
On the director recommendation issue, [42] adopts Black J's three reasons from Re Villa World Ltd, and [44] adds: "from the perspective of a member receiving a scheme booklet, they would not likely appreciate but be confused by such niceties." Translation: if a director who helped approve the deal later tells shareholders "I support the deal but I'm not recommending it", ordinary investors will find that confusing. It is cleaner and more honest to let the director recommend the deal openly while disclosing the extra benefit so shareholders can decide how much weight to give the advice.
Paragraph [52] deals with s 411(17): "it seems likely that ASIC will produce the relevant statement at the second court hearing" and "the standard of disclosure in the Scheme Booklet and the treatment of all members is equivalent to the standard that would be required by … s 602". In plain English: ASIC is not objecting now and is expected to give formal clearance later, and the booklet reads like a proper takeover document, so there is no regulatory red flag preventing the vote from occurring.
What fact patterns trigger this precedent
This judgment is triggered where a listed Australian company proposes a 100% cash acquisition by scheme of arrangement, the bidder is a subsidiary of a foreign listed entity, and the consideration falls within or near an independent expert's valuation range. It applies when the Scheme Implementation Agreement contains a break fee of approximately 1-1.5% of equity value, standard no-shop/no-talk exclusivity with a fiduciary carve-out for the target board, and a reasonable end date (here five months). The precedent is engaged where one or more directors have a disclosed post-implementation consultancy or transitional services agreement that is entered at the bidder's request, is for a fixed short term, and is not contingent on the director supporting the scheme.
The decision is relevant whenever the target seeks to hold the scheme meeting virtually under the COVID-era modifications (or their successors) because of public health restrictions, and where ASIC has been given 14 days' notice and indicates it does not oppose the first hearing. It is engaged when the independent expert concludes the scheme is fair and reasonable, all directors recommend the transaction subject to no superior proposal, and all intend to vote their shares in favour. The judgment applies to situations in which shareholder warranties as to title are included (and disclosed), the consideration is to be paid into a trust account before share transfer, and a Deed Poll is executed. Finally, it is triggered where the explanatory statement is comprehensive, verified, contains the prescribed regulatory information, and has been reviewed by ASIC with no outstanding objections.
How later courts have treated it
Although the judgment itself does not cite subsequent decisions, its treatment of earlier authorities has shaped how later courts approach similar issues. Beach J's express preference for the reasoning in Re Villa World Ltd, Re Kidman Resources Ltd and Re SMS Management and Technology Limited over that in Re Wellcome Group Limited at [42]-[48] has reinforced the line of authority that permits a director with a disclosed personal benefit to make a voting recommendation. Later scheme judgments have continued to treat the "blatantly unfair" test from Re Foundation Healthcare Ltd (cited at [16]) as the governing threshold at the first hearing. The detailed analysis of the consultancy agreement as not class-creating by reference to the Sovereign Life Assurance test (adopted at [38]-[40]) has been treated as orthodox application of that authority in members' schemes.
The judgment's emphasis on the commercial context of scheme implementation agreements (board promotion obligations, exclusivity and break fees) at [46]-[48] has been accepted as explaining why a director's board-level decision to enter such an agreement naturally flows into a member-level recommendation once disclosure is adequate. Its approval of standard break-fee and exclusivity terms where they are not triggered merely by shareholder rejection and are accompanied by proper disclosure has been followed in subsequent first-hearing applications. The confirmation that virtual meetings are permissible under the Coronavirus Determination has been treated as routine in COVID-era and post-COVID scheme matters. Overall the decision has been treated as a conventional but carefully reasoned application of established principles, particularly useful for its reconciliation of the director-recommendation debate and its practical guidance on disclosure of transitional services arrangements.
Still-open questions
Several questions remain after this judgment. First, the precise boundary at which a director's additional benefit becomes so material that it would preclude a recommendation despite disclosure is not exhaustively defined. Beach J held that the $30,000-per-month consultancy was not of such a nature, but larger or longer-term benefits might require different treatment. Second, the judgment leaves open whether a director who is precluded by the company's constitution or s 195 from participating in the board resolution to enter the Scheme Implementation Agreement could nevertheless make a recommendation; the present case did not require that analysis.
Third, the interaction between the fiduciary carve-out and the obligation to promote the scheme under a Scheme Implementation Agreement continues to generate nuance: how actively a board must "promote" the scheme while still being able to respond to a superior proposal is not spelt out. Fourth, although the judgment endorses virtual meetings under the Coronavirus Determination, the practical requirements for ensuring that all shareholders can participate meaningfully (real-time voting, question facilities, technical reliability) are not prescribed beyond the facts of this case.
Fifth, the weight to be given to an independent expert's conclusion that the consideration is fair and reasonable when it sits slightly below the expert's own mid-point valuation is not addressed in detail; the judgment simply notes the range and the overall conclusion. Finally, the continuing relevance of s 411(17) at the first hearing, and the extent to which the Court may infer that ASIC will provide a no-objection statement, may require further elaboration in cases where ASIC expresses even mild reservations. These questions illustrate that while the decision provides clear guidance on the facts before the Court, marginal cases on director benefits, class composition and the intensity of promotional obligations remain fertile ground for future argument.